Pharmafile Logo
Pharmafocus logo
Advanced Search

research and development

Showing 15 posts of 209 posts found.

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

September 12, 2025
Innovation Award 2025, PlasmidFactory, cell and gene therapy, medical communications, research and development

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with the Innovation Award 2025 of …

News

Richmond Pharmacology promotes Patrick Ramiah to Director

September 8, 2025
Clinical Trial Services, Director of Clinical Project Delivery & Operational Excellence, Richmond Pharmacology, corporate, research and development

Patrick Ramiah has been promoted to Director of Clinical Project Delivery & Operational Excellence at Richmond Pharmacology, effective from 1 …

Appointment

AAX Biotech announces collaboration for cardiovascular antibody therapy

May 8, 2025
Research and Development AAX Biotech, Cardiology, antibody therapies, collaboration, research and development

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of antibody-based therapies targeting cardiovascular disease. …

News

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

April 10, 2025
Research and Development Alzheimer's disease, Neurology, TauRx Pharmaceutics, research and development

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over …

News

Enosium Life Science acquires RWEality

April 3, 2025
Business Services, Consultancy Consultancy, Corporate, Enosium Life Sciences, RWEality, acquisition, life sciences, research and development

Enosium Life Science, which specialises in life sciences, has acquired RWEality, a consultancy focused on public policies, technology and healthcare …

News

Usama Dar appointed as chief product and technology officer at CluePoints

April 2, 2025
Research and Development Pharmacy, clinical trial analysis, cluepoints, pharma, research and development

CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Dar’s …

Appointment

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 1, 2025
Research and Development Cardiology, Novo Nordisk, cardiometabolic diseases, research and development

Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …

News

Corcept’s relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint

April 1, 2025
Research and Development Corcept Therapeutics, Oncology, ovarian cancer, research and development

Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the company’s phase …

News

Secarna Pharmaceuticals to announce positive new data at cancer research conference

April 1, 2025
Research and Development Oncology, Secarna Pharmaceuticals, oncology, research and development

Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) …

News

Research collaboration announced between Oxford University and GSK

January 27, 2025
Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development

The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …

News

NMD Pharma’s Charcot-Marie-Tooth disease treatment granted ODD by FDA

January 6, 2025
CMT, FDA, NMD Pharma, Orphan Drugs, Pain, nervous system, research and development

Biotech company NMD Pharma has announced that the US Food and Drug Association (FDA) have granted its Charcot-Marie-Tooth (CMT) disease …

News

Merck KGaA announces new Senior Vice President, Head of Global Affairs

July 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development

Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …

Appointment
gilead-sciences

Gilead quietly drops drugs from line up alongide Q3 results

November 2, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abzena, Gilead, research and development

Gilead Sciences followed Pfizer in discreetly dropping a drug alongside its third quarter profit reports. The drug in question, for …

News
pancreatic_cancer_research

Heart disease drug development is falling

August 30, 2016
Manufacturing and Production, Research and Development cardiovascular disease, heart disease, research and development

The number of drugs currently in development to combat heart disease has fallen in the last 20 years, it has …

News
lilly_entrance_web

Eli Lilly showcases emerging pipeline to investors

May 25, 2016
Research and Development Eli Lilly, investors, lilly, pipeline, research and development

Eli Lilly and Co (NYSE: LLY) has showcased its emerging pipeline to potential investors, highlighting its potential to launch 20 …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026